Detail akcie Poniard online

Business Summary: Poniard Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of oncology products to impact the lives of people with cancer. It develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The Company has offices in San Francisco, California; and Seattle, Washington in United States.
Financial Summary: BRIEF: For the nine months ended 30 September 2011, Poniard Pharmaceuticals, Inc. revenues remained flat at $0K. Net loss applicable to common stockholders decreased 57% to $11M. Revenues reflect market conditions. Lower net loss reflects Research and development decrease of 87% to $1.1M (expense), Interest expense decrease of 96% to $70K (expense), Restructuring decrease from $1.6M (expense) to $0K.